BioSyntech, Inc.
BSYI
$0.00
$0.000.00%
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Revenue | -87.18% | -- | 286.89% | -87.16% | -81.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -87.18% | -- | 286.89% | -87.16% | -81.94% |
| Cost of Revenue | -30.77% | -- | 166.67% | -89.81% | -82.19% |
| Gross Profit | -115.38% | -- | 449.02% | -85.38% | -81.94% |
| SG&A Expenses | 16.73% | 59.71% | -20.45% | -31.73% | -44.76% |
| Depreciation & Amortization | 24.10% | -16.49% | -0.77% | -34.85% | -8.46% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.94% | 2.04% | -41.87% | -54.53% | -27.03% |
| Operating Income | 14.78% | 3.16% | 43.66% | 52.50% | 26.52% |
| Income Before Tax | 14.31% | -14.01% | 1.30% | -1.22% | -56.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.31% | -14.01% | 1.30% | -1.22% | -56.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.31% | -14.01% | 1.30% | -1.22% | -56.32% |
| EBIT | 14.78% | 3.16% | 43.66% | 52.50% | 26.52% |
| EBITDA | 15.74% | 2.65% | 44.40% | 52.67% | 26.06% |
| EPS Basic | 22.37% | -3.64% | 7.02% | -0.78% | -55.60% |
| Normalized Basic EPS | -10.59% | -3.70% | 6.62% | 13.75% | -8.97% |
| EPS Diluted | 22.37% | -3.64% | 7.02% | -0.78% | -55.60% |
| Normalized Diluted EPS | -10.59% | -3.70% | 6.62% | 13.75% | -8.97% |
| Average Basic Shares Outstanding | 10.40% | 9.96% | 6.11% | 0.69% | 0.63% |
| Average Diluted Shares Outstanding | 10.40% | 9.96% | 6.11% | 0.69% | 0.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
